文献速递慢阻肺

早产儿存活者全生命周期呼吸健康路径解析

Unravelling the respiratory health path across the lifespan for survivors of preterm birth.
PubMed 文献 · Lancet Respir Med · 2023-11-14

本文探讨早产对肺功能全生命周期的影响,指出早产儿存活者存在肺发育异常、肺功能峰值降低及肺功能下降加速,增加慢阻肺风险;提出多维模型确定早产相关肺病表型以优化管理。

要点

  • 早产儿存活者肺发育异常、肺功能峰值降低,慢阻肺风险增加。
  • 提出多维模型确定早产相关肺病个体表型,以优化管理。

核心结论

  • 早产儿存活者全生命周期肺功能异常风险增加,需呼吸界关注并优化管理。

研究设计与样本

  • Personal View,描述早产对肺功能全生命周期影响并综述机制与管理。

主要发现

  • 早产儿存活者可有肺发育异常、肺功能峰值降低及肺功能下降加速,增加慢阻肺风险。

临床怎么用

  • 提出多维模型确定早产相关肺病个体表型,作为优化管理第一步。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many survivors of preterm birth will have abnormal lung development, reduced peak lung function and, potentially, an increased rate of physiological lung function decline, each of which places them at increased risk of chronic obstructive pulmonary disease across the lifespan. Current rates of preterm birth indicate that by the year 2040, around 50 years since the introduction of surfactant therapy, more than 700 million individuals will have been born prematurely-a number that will continue to increase by about 15 million annually. In this Personal View, we describe current understanding of the impact of preterm birth on lung function through the life course, with the aim of putting this emerging health crisis on the radar for the respiratory community. We detail the potential underlying mechanisms of prematurity-associated lung disease and review current approaches to prevention and management. Furthermore, we propose a novel way of considering lung disease after preterm birth, using a multidimensional model to determine individual phenotypes of lung disease-a first step towards optimising management approaches for prematurity-associated lung disease.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Simpson SJ, Du Berry C, Evans DJ, et al. Unravelling the respiratory health path across the lifespan for survivors of preterm birth. Lancet Respir Med. 2023. PMID: 37972623. doi:10.1016/S2213-2600(23)00272-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。